University of Pennsylvania logo

University of Pennsylvania

North America, Pennsylvania, United States, Philadelphia

Description

The University of Pennsylvania is an American private Ivy League Research University that excels in producing future leaders.

Investor Profile

University of Pennsylvania has made 11 investments, with 1 in the past 12 months and 18% as lead.

Stage Focus

  • Pre Seed (27%)
  • Series A (27%)
  • Grant (27%)
  • Series Unknown (9%)
  • Seed (9%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Genetics
  • Manufacturing
  • Software
  • Apps
  • Hospital
  • Biopharma
  • Bioinformatics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does University of Pennsylvania frequently co-invest with?

Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Gilead Sciences
North America, California, United States, Foster City
Co-Investments: 2
Parker Institute for Cancer Immunotherapy
North America, California, United States, San Francisco
Co-Investments: 2
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
Tellus BioVentures
North America, New York, United States, Florida
Co-Investments: 2
Be The Match BioTherapies
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
Ping An Ventures
Asia, Shandong, China, Pudong
Co-Investments: 2
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by University of Pennsylvania?

Jochi

Philadelphia, Pennsylvania, United States

SaaS

AnalyticsBusiness IntelligenceEdTechSoftware
GrantMay 1, 2024
Amount Raised: $280,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
Series UnknownNov 14, 2023
Amount Raised: $15,000,000
Baleena

Philadelphia, Pennsylvania, United States

Baleena is a clean tech venture tackling microplastic fiber pollution in laundry

CleanTechGreen Consumer GoodsHardwareSustainability
Pre SeedApr 20, 2022
Amount Raised: $250,000
Grapevine

New York, New York, United States

Grapevine Technologies is a custom-made platform offers healthcare supply chain.

Health CareSoftwareSupply Chain Management
Pre SeedApr 1, 2022
Amount Raised: $2,000,000
Adni (Formerly Lumify)

San Francisco, California, United States

Adni is the all-in-one clinician engagement platform that improves recruiting & retention.

AppsHealth CareHospital
Pre SeedAug 31, 2021
Amount Raised: $275,000
Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AMay 18, 2021
Amount Raised: $76,000,000
Behavior Change for Good Initiative

Philadelphia, Pennsylvania, United States

Behavior Change for Good Initiative is a education center for advance science and practice of behavior change.

EducationNon ProfitUniversities
GrantSep 6, 2018
Amount Raised: $2,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AApr 19, 2018
Amount Raised: $35,000,000
Avisi Technologies

Redwood City, California, United States

Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.

Health CareMedical DeviceNanotechnology
GrantApr 19, 2018
Amount Raised: $200,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AJan 23, 2018
Amount Raised: $100,000,000